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Introduction: 
The primary goal of root canal treatment is the prevention and treatment of apical 
periodontitis. There is overwhelming evidence for the essential role of microbial agents 
in dental pulp infection and the pathogenesis of apical periodontitis. The presence of 
bacteria in the necrotic dental pulp of teeth with associated pathologic conditions was 
reported more than a century ago when Miller hypothesized in 1894 that microorganisms 
are the causative agents of endodontic disease (Miller 1894). However, it was not until 
more than a half century later, when the causal relationship between periapical 
inflammation and bacterial infection was convincingly demonstrated. In the classic study 
by Kakehashi and coworkers in 1965, it was shown that pulpal necrosis and periapical 
inflammation developed in rats subjected to mechanical pulp exposure and kept exposed 
to the conventional microbial environment of the oral cavity. Whereas germ-free animals 
demonstrated minimal pulpal inflammation and no periapical destruction (Kakehashi et a1 
1965) 
In the US, it is estimated that more than 24 million endodontic procedures are 
performed annually, and up to 5.5% of these procedures are apical surgery, perforation 
repair, and apexification procedures (Roberts et a1 2008, Nash et a1 2002). Recent meta- 
analysis reports estimated endodontic treatment success rate to be between 68% and 85% 
(Iqbal et a1 2008, Ng et a1 2007). Surgical placement of a root end filling has been 
increasingly used in the management of endodontic failure. Mineral trioxide aggregate 
(MTA) is the most widely used root end filling material in surgical endodontics. MTA is 
shown to be biocompatible. The following literature review aims to discuss apical 
periodontitis and its causative factors. Surgical endodontics and wound healing, as well 
as bone cells and regulation of bone metabolism. MTA composition and 
biocompatibility with periapical tissue will be reviewed. 
Apical periodontitis: 
Apical periodontitis is an inflammatory disease of periradicular tissues caused by 
persistent microbial infection within the root canal system of the affected tooth 
(Kakehashi et a1 1965, Sundqvist 1976, Nair 2006). The infected and necrotic pulp offers 
a selective habitat for the organisms (Fabricius et a1 1982, Nair 2006).The microbes grow 
in sessile biofilms, aggregates, coaggregates, and as planktonic cells suspended in fluid 
phase (Nair 2006). Planktonic bacteria have easy access to nutrients, multiply rapidly and 
often are highly motile (Olson et a1 2002). They are more susceptible to antibiotics, 
environmental and host factors. Sessile bacteria grow in colonies encased by an 
extracellular matrix of carbohydrates or exopolysaccharides (Olson et a1 2002). These 
colonies often are called a bacterial biofilm. Sessile bacteria have limited nutrient, grow 
more slowly and have restricted mobility (Olson et a1 2002). 
A biofilm (Costerton et a1 2003) is a community of microorganisms embedded in 
an exopolysaccharide matrix that adheres onto a moist surface (Nair 2006). Apical 
periodontitis persisting after root canal treatment is believed to be harder to eradicate 
compared to apical periodontitis affecting teeth without previous endodontic treatment. 
Endodontically treated teeth with apical periodontitis present the clinician with a resistant 
microbiological etiology, and limited treatment options compared to apical periodontitis 
in non-root canal treated teeth (Nair 2006). 
A clear understanding of the microbiology and pathology the two types of apical 
periodontitis is essential to deliver optimum treatment. Intra-radicular microorganisms 
are the main etiological agents of apical periodontitis (Kakehashi et a1 1965, Sundqvist 
1976), hence the treatment consists of eradicating or reducing the microbial population 
and preventing re-infection by root canal filling (Nair et a1 2005). 
Once this is achieved, hard tissue healing and reduction of periapical radiolucency 
is expected (Strindberg 1956, Grahnen & Hansson 1961, Seltzer & Bender 
1963, Storms 1969, Molven 1976, Kerekes & Tronstad 1979, Molven & Halse 1988, 
Sjogren et a1 1990 & 1997, Sundqvist et a1 1998). However, some periapical tissues will 
not heal. Inadequate aseptic control, poor access cavity design, untreated root canals, 
insufficient instrumentation, and leaking temporary or permanent restorations are 
common problems that may lead to persistent apical periodontitis (Sundqvist & Figdor 
1998, Nair 2006). Complex apical third root canal anatomy and factors in periapical 
tissue that interfere with post-treatment healing are the main reasons for persistent apical 
lesions despite the clinician's careful instrumentation and meticulous microbiological 
control (Nair 2006). 
Microbial Factors: 
Intra-radicular infection 
Several histological studies have shown bacteria present in the root canal system 
of teeth with asymptomatic periapical periodontitis. Bacteria were mostly located in the 
uninstmmented recesses of the main canals, isthmuses, and accessory canals (Nair 1990, 
Nair 2006). The bacteria existed as biofilms and were not removed by instrumentation 
and irrigation with NaOC1. Considering the complex root canal anatomy and difficulty to 
eradicate bacterial biofilm, it is unlikely that clinicians will be able to get a bacteria free 
root canal system. 
The endodontic microbiology of treated teeth is less understood than that of 
untreated infected necrotic dental pulps (Nair 2006). Enterococcus faecalis is the most 
recovered organism from the canals of failed root filled teeth, with a prevalence ranging 
from 22% to 77% of cases analyzed (Moller 1966, Molander et a1 1998, Sundqvist et a1 
1998, Peciuliene et a1 2000, Hancock et a1 2001, Pinheiro et a1 2003, Siqueira & Rocas 
2004, Fouad et a1 2005, Nair 2006). The organism is resistant to most of the intra-canal 
medicaments (Bystrom et a1 1985), and can tolerate a pH up to 11.5, which may be one 
reason why this organism sometimes survives antimicrobial treatment with calcium 
hydroxide dressings. This resistance occurs because of its ability to regulate internal pH 
with an efficient proton pump (Evans et a1 2002). Enterococcus faecalis can survive 
prolonged starvation (Figdor et a1 2003). It can grow as a mono-infection in treated 
canals in the absence of synergistic support from other bacteria (Fabricius et a1 1982). 
Therefore, E. faecalis is regarded as being a very recalcitrant microbe among the 
potential etiological agents of persistent apical periodontitis (Nair 2006). 
Chen et a1 (2009) reported that Herpes-viruses are present but not required for the 
development of acute apical abscesses and cellulitis of endodontic origin. Li et a1 (2009) 
reported that Epstien-Barr virus may be associated with irreversible pulpitis and apical 
periodontitis. Although not reported in teeth with previous root canal treatment, further 
research is required to exclude viruses as a potential factor in persistent apical 
periodontitis. 
Extra-radicular infection 
Actinomycosis is a chronic, granulomatous, infectious disease in humans and 
animals caused by the genera Actinomyces and Propionibacterium (McGhee et a1 
1982, Nair 2006). Actinomycotic organisms are able to establish extraradicular infections 
and can perpetuate the inflammation at the periapex even after proper root canal 
treatment (Nair 2006). Therefore, periapical actinomycosis is important in endodontics 
(Sundqvist & Reuterving 1980, Nair & Schroeder 1984, Happonen et al. 1985, Happonen 
1986, Sjogren et a1 1988, Nair et a1 1999, Nair 2006). Actinomyces israelii and P. 
proprionicum are consistently isolated and characterized from the periapical tissue of 
teeth which did not respond to proper non-surgical endodontic treatment (Happonen 
1986, Sjogren et a1 1988, Ricucci & Siqueira 2008). 
In his review (Nair 2006) summarized all the possible causative agents of 
persistent apical periodontitis. They are: (i) intraradicular infection persisting 
in the complex apical root canal system,(ii) extraradicular infection, generally in the form 
of periapical actinomycosis, (iii) extruded root canal filling or other exogenous materials 
that cause a foreign body reaction,(iv) accumulation of endogenous cholesterol crystals 
that irritate periapical tissues, (v) true cystic lesions, and (vi) scar tissue healing of the 
periapex. In both poorly and properly treated teeth, residual microbes in the apical 
portion of the root canal system are the most important etiological factor, while the other 
remaining factors occur rarely. Treatment options for such cases are retreatment, surgery 
or extraction. 
Surgical Endodontic Treatment: 
In the US, it is estimated that more than 24 million endodontic procedures are 
performed annually, and up to 5.5% of these procedures are apical surgery, perforation 
repair, and apexification procedures (Roberts et a1 2008, Nash et a1 2002). Recent reviews 
estimated the cumulative endodontic success rates, with and without apical periodontitis, 
to be between 68% and 85% (Iqbal et a1 2008, Ng et a1 2007).Surgery is performed on 
failed root canals due to complex root canal anatomy, perforations, instrument fractures, 
ledges, and restorative reasons where crowns and posts cannot be removed. Apical 
surgery involves accessing the root apical third, removal of all granulation tissue, root 
end resection, root end cavity preparation and placement of root end filling material. 
Following the surgical procedure the tissue undergoes changes to restore its structure and 
function. The ultimate goal of every surgical procedure is regeneration of all lost tissues. 
The next section will discuss healing after surgical procedures in soft tissue and bone. 
Healing: 
A wound is defined as any injury that causes disruption of the anatomical 
continuity and/or function of living tissues and results in cellular injury and death 
(Krawczyk 1978). All surgical procedures involve intentional wounding of specific 
tissues and are dependent upon the wound healing responses of those tissues for success 
(Harrison 1991). Wound healing is, in turn, dependent upon the type of tissues wounded 
and the type of wound inflicted (Harrison 1991). 
Wound healing is dependent upon: (a) the type of tissue wounded and (b) the type 
of wound the tissue receives (Krawczyk 1978, Harrison 1991). It involves a complex 
series of biological events. It can be divided into; (a) clotting and inflammation, (b) 
epithelial healing, (c) connective tissue healing, and (d) maturation and remodeling. 
Clotting and Inflammation: 
Surgical wounding causes disruption of the microvasculature supplying the 
mucoperiosteal tissues. The first step of healing is to achieve hemostasis. Vascular injury 
releases plasma fractions (eg. albumin, fibrinogen, globulins, fibronectin, and 
plasminogin) and formed elements (erythrocytes, platelets, and leukocytes) into the 
surrounding tissues (Harrison 1991). A plethora of humoral and cellular biochemical 
mediators are activated, causing vasodilatation and increased permeability in intact 
microvessels, as well as intravascular platelet aggregation (platelet plugs) in severed 
vessels. The activated biochemical mediators influence both the clotting and 
inflammatory mechanisms (Harrison 1991). 
Clotting: 
Extrinsic and intrinsic clotting mechanisms are triggered, each giving rise to a 
cascading sequence of events leading to clot formation (Boucek 1984, Harrison 1991). 
The crucial step in both clotting mechanisms is the conversion of fibrinogen to fibrin and 
formation of fibrin clot. 
The fibrin clot form strengthens the initial platelet plug (Harrison 1991). A few 
hours after clot formation, the fibrin strands undergo contraction this provides a tenuous 
attachment between opposing wound edges and forms pathways of migration, first for 
inflammatory cells and, subsequently, for cells which will affect repair or regeneration 
(Ruben et a1 1960, Harrison 1991). 
Inflammation: 
The response of all living tissues to all forms of injury is inflammation, which 
involves vascular, humoral, and cellular reactions at the injury site and prepares the site 
for healing (Boucek 1984, Harrison 1991). Healing is dependent upon the inflammatory 
process to create a favorable environment for cellular metabolism by removing 
microorganisms, necrotic or damaged tissue, and particulate matter (Harrison 1991). 
Inflammation dominates the early stages of wound healing. The more rapidly the 
inflammatory process can create an environment conducive to rapid wound healing 
(Harrison 199 1). 
The events of the inflammatory response are mediated by the production, 
activation, and release of inflammatory mediators. The interactions between 
inflammatory mediators are extremely complex (Harrison 199 1). Histamine and 
Serotonin cause hernodynamic changes in the microvasculature, resulting in vasodilation, 
an increased blood volume, and a decreased rate of flow (Harrison 1991). Leukocytes 
become displaced to the periphery of the blood stream and actively pass through the 
vessel wall and proceed to the wound site (Harrison 199 1). 
The first wave of leukocytes is largely comprised of polymorphonuclear 
neutrophils (PMN's) which are the most active cells in the early inflammatory response, 
phagocytizing microorganisms, particulate matter, and cellular debris (Boucek 1984, 
Harrison 1991). Rapid destruction of microorganisms quickly reduces the need for 
continued migration of these cells and the chemotactic mechanisms responsible for their 
early migration are soon deactivated (Boucek 1984, Harrison 199 1). Under ideal wound- 
healing conditions, PMN activity subsides and their numbers decrease rapidly between 24 
and 48 h after wounding (Boucek 1984, Harrison 1991). 
After the initial influx of PMN's, plasma-derived monocytes appear in increasing 
numbers, undergoing rapid morphological and functional changes under the influence of 
inflammatory mediators to become activated macrophages. Macrophages become the 
predominant cell in the wound site (Krawczyk 1978, Trowbridge 1983, Harrison 1991). 
Macrophages release biochemical mediators which stimulate fibroblast and migration, 
collagen and ground substance synthesis, and angiogenesis (Harrison 1991). The 
macrophages are control the extent and degree of the immediate inflammatory response, 
creating an environment in which connective tissue healing can occur, and directing the 
ingress of cells (fibroblasts, undifferentiated ectomesenchymal cells, endothelial and 
smooth muscle cells) that will affect repair or regeneration of the wound site (Krawczyk 
1978, Hunt et a1 1984, Harrison 1991). 
Epithelial Healing: 
Epithelial cells in the wound edges undergo specific changes within hours after 
surgical wounding. The basal and suprabasal prickle cells undergo dedifferentiation, 
acquire the potential for amoeboid movement, and develop phagocytic capabilities 
(Krawczyk 1978, Melcher 1969, Rubben 1980, Harrison 199 1). Spaces appear between 
these cells as desmosomal attachments are loosened. The cells become elongated and 
begin to migrate across the fibrin scaffolding of the clot (Harrison 1991). The basal and 
suprabasal ceils adjacent to these migrating cells of the wound edge subsequently begin 
to undergo mitosis at a high rate. The migrating cells move as a monolayer or sheet of 
cells, which may be several cells in thickness, toward the center of the surface of the 
wound until cellular contact is made with epithelial cells migrating from the opposing 
wound edge (Melcher 1969, Harrison 199 1). 
Connective Tissue Healing: 
The connective tissue healing phase is the most complex of the wound healing 
phases. It begins with the formation of the epithelial seal and progresses rapidly after 
epithelial barrier formation (Harrison 1991). The primary connective tissue cell involved 
in this phase is the fibroblast which synthesizes ground substance and collagen, the 
essential elements of regeneration or repair (Rubben 1980, Harrison 1991). Fibroblasts 
are mobilized primarily from undifferentiated ectomesenchymal cells in the perivascular 
tissues surrounding the wound site (Boucek 1984, Harrison 1991). Fibroblasts begin the 
synthesis of collagen, glycosaminoglycans, glycoproteins, and fibrous proteins (Harrison 
1991). The first-formed collagen appears as a fine, branching network of delicate type III 
(reticulin) fibers formed by young fibroblasts. Mature fibroblasts soon initiate synthesis 
of type I collagen. As collagen molecules enter the extracellular environment, 
angiogenesis factors are released from macrophages and other sources, stimulating the 
migration of endothelial and smooth muscle cell chords from the microvasculature of the 
wound edges into the wound site (Krawczyk 1978, Trowbridge 1983, Harrison 1991). 
Maturation and Remodeling: 
After sufficient collagen is produced, the number of fibroblasts in the former 
wound site decreases and there is a concomitant reduction in the vascular channels. This 
signals the end of the connective tissue healing phase and the beginning of the maturation 
and remodeling phase (Harrison 1991). Under ideal healing conditions the later phase 
may begin as early as a few days after simple incisional wounding in oral mucoperiosteal 
tissues (Harrison 1991). Collagen fibers undergo pronounced changes in form, bulk, 
strength, and orientation, during the maturation phase (Harrison 1991). Maturation 
involves simultaneous collagen deaggregation and reaggregation which results in a 
change in the architecture of the fibers to an organized pattern and density similar to 
those of normal adjacent tissues (Kline&Weiss1966, Harrison 1991). As the fiber pattern 
and density take on a normal appearance, the fibrohlast population decreases to the same 
level as adjacent tissues (Harrison 1991). This step in healing process is followed closely 
by the formation and remodeling of bone. The next section provides a detailed overview 
of the bone structure and metabolism. 
Bone: 
Bone is a specialized connective tissue. It is highly mineralized with calcium 
phosphate in the form of hydroxyapatite ([Ca3(P04)2] Ca(OH)2 ) (Datta et a1 2008). Bone 
provides the body with rigidity, shape, protection, and support. Bone undergoes 
continuous remodeling for repair and adaptation to body needs. In childhood bone 
formation exceeds resorption, while both processes are balanced in adult life. Bone 
strength is regulated thorough a carefully regulated process involving multiple cells and 
mediators (Dattaet a1 2008). 
Bone structure: 
There are two types of mature bone: (1) cortical or compact bone which has a 
dense, ordered structure; (2) cancellous or trabecular bone which is lighter, less compact 
and has an irregular structure (Datta et a1 2008). Cortical or compact bone is found 
mainly in the shaft of long bones and the surfaces of flat bones. It is composed of bone 
laid down concentrically around central canals known as Haversian systems. These 
contain blood vessels, lymphatics, nerves and connective tissue. A concentric layer of 
rings or lamellae of bone matrix surround each Haversian canal. Within the lamellae are 
tiny spaces called lacunae containing osteocytes (Datta et a1 2008). Trabecular or 
cancellous bone forms the ends of long bones and the inner parts of flat bones. It contains 
interconnecting plates and bars called trabeculae, and have a honeycomb appearance. The 
trabeculae are aligned along lines of stress; this connectivity adds considerably to its 
strength. 
Trabecular bone is ideally suited to withstanding compressive stress. Another 
important element in the structure of bone is the collagen network. In adults, collagen 
fibers adopt a preferential orientation resulting in the formation of lamellar bone. In 
cortical bone the lamellae are concentrically arranged, and in trabecular bone they are 
parallel to one another (Datta et a1 2008). Woven bone is formed in the growing skeleton 
and in various pathological conditions in the adult. This type of bone has a random 
arrangement of collagen fibers, with non-uniformly sized and distributed osteocytes. 
In general each bone has an outer layer of cortical bone overlying trabecular bone 
and the medullary cavity. The cortical bone has an outer membrane called the 
periosteum. The periosteum has two layers: an outer and an inner layer. The inner layer 
has osteogenic potential and lays down new bone allowing the bone to enlarge, a process 
known as periosteal apposition. The inner surface of the cortex has another lining called 
the endosteum. Bone tends to undergo resorption from the endosteal surface. Both the 
periosteum and endosteum contain osteoblasts and osteoclasts and their progenitors. 
Osteoblasts and osteoclasts function in a coordinated manner, to carry out remodeling, 
growth and repair (Datta et a1 2008). 
Bone cells: 
Osteoclasts and osteoblasts carry out bone metabolism. Osteoclasts function to 
resorb existing bone and are active early in the bone remodeling cycle. They are derived 
from fusion of cells of monocyte lineage. Osteoclasts are multinucleated, they have apical 
and basolateral poles that differ both morphologically and functionally. The osteoclast's 
apical pole has a ruffled membrane that is oriented toward the bone matrix and is the site 
for secretion of enzymes and protons that are essential for resoprtion of bone. The 
osteoclast's basolateral pole faces toward the local environment and it has receptors for 
hormones and other substances such as, fibroblasts growth factor, transforming growth 
factor and platelet derived growth factor (Christenson 1997). 
The osteoclast functions by attaching the outside edge of its apical membrane to 
the mineralized matrix on the bone's surface, creating a microenvironment termed a 
"sealing zone." This zone provides a bone-resorbing compartment where the pH is 
lowered when protons and potent enzymes such as acid phosphatase, aryl-sulfatases, and 
metalloproteinases are released. This microenvironment functions to resorb bone and 
form a depression termed a lacuna (Christenson 1997). 
Osteoblasts are responsible for bone formation. After formation of lacunae by the 
osteoclasts, osteoblasts cells lay down osteoid, a replacement bone matrix. Osteoblasts 
derive from mesenchymal progenitors that can differentiate into chondrocytes or 
osteoblasts (Fig I), adapted from Maes et a1 (2007). The transcription factors involved in 
driving the cell to a chondrocyte fate are Sox9, L-Sox5, and Sox6, while osteoblast 
differentiation requires Runx2 and later Osx and p-catenin. Progressive osteoblast 
differentiation from committed osteoblast progenitor cells is characterized by changes in 
gene expression, providing markers that typify specific stages. Runx2 is the earliest 
marker of preosteoblasts, followed by Osx. Preosteoblasts further differentiate into 
osteoblasts that produce large amounts of type I collagen (Collagen 1) and later 
mineralize the osteoid matrix as mature osteoblasts expressing osteocalcin. Eventually, 
the cells can become entrapped within the bone matrix as osteocytes, remain quiescently 
at the surface of the bone as lining cells, or die by apoptosis, Maes et a1 (2007). 
Osteoblasts have one nucleus and an extensive network of rough endoplasmic reticulum 
(ER), which is responsible for synthesis of bone matrix proteins. After osteoblasts have 
filled the lacunae with osteoid, the process of bone formation is halted (Christenson 
1997). 
Some of the osteoblasts are entrapped in the bone matrix where they become 
osteocytes. Despite their relative inactivity compared with osteoblasts, osteocytes play a 
central role in the determination and maintenance of bone structure (Mikuni- 
Takagakil999, Han et a1 2004, Holmbeck et a1 2005, Kamioka et a1 2001, Zhao et a1 
2002, Datta et a1 2008). Osteocytes embedded in bone interact with other osteocytes and 
bone cells by an elaborate network of dendritic processes, which run inside lacunar 
cannaliculi. There is emerging evidence that osteocytes function as mechanosensory 
cells, and dendritic processes carry the signaling molecules responsible for bone 
resorption process. (Duncan& Turner 1995, Pavalko et a1 2004, Tarbell et a1 2005, Datta 
et a1 2008) 
Bone Metabolism Cycle: 
The bone cycle proceeds in one direction only, in a well-coordinated, process 
controlled by hormones and other factors via mechanisms which are incompletely 
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understood at present (Christenson 1997). Bone remodeling always begins in the 
quiescent phase. After activation is initiated, osteoclasts are attracted to the new bone 
forming unit or bone mineralization unit (BMU). Osteoclasts erode the bone matrix, 
forming lacunae. This process takes about 10 days and osteoclasts normally resorb bone 
until the lacunae are approximately 100 pm in diameter and 50 pm deep. Resorption is 
then halted and osteoblasts are recruited to the BMU site. Osteoblasts begin at the bottom 
of lacunae and lay down the osteoid matrix, comprised mainly of type 1 collagen. It takes 
about 80 days to fill the lacunae. The newly formed matrix is then mineralized with 
hydroxyapatite, giving the BMU tensile strength. The remodeled area then passes into the 
quiescent phase to complete the bone cycle (Christenson 1997). 
Regulation of bone metabolism: 
Bone metabolism and regulation is an area under extensive research, however the 
exact mechanisms are not yet completely understood. Fibroblast growth factors (FGF) 
increase both osteoblast proliferation and collagen synthesis within bone (Canalis et a1 
1987). The FGFs precise mechanism of action is unknown (Abraham et a1 1986). Insulin- 
like growth factors (IGF, type I and 11) increase the protein content of osteoid by 
promoting preosteoblastic proliferation and by decreasing collagen degradation as well as 
increasing protein synthesis (Forlik et a1 1988, Canalis et a1 1989). 
Transforming growth factors (TGF) are important in the maturation process. They 
stimulate the precursor cells committed to becoming osteoblasts (Centrella et a1 1988). 
TGFs appear to stimulate the synthesis of alkaline phosphatase. TGF is also related to 
synthesis of type 1 collagen (Bortell et a1 1990). Platelet derived growth factor (PDGF) 
found in the bone matrix also stimulates osteoprogenitor cells and protein synthesis 
(Canalis 198 1). 
Both osteoblasts and osteoclasts are responsive to various prostaglandins, which 
may mediate their response to other growth factors. Tissue necrosis factors (TNF) 
increase collagen synthesis in preosteoblasts, but appear to decrease collagen synthesis in 
more mature cells (Raisz & Martin 1984). Colony stimulating factors (CSF) are 
implicated in osteoclast proliferation and may be involved in the signaling mechanism 
between osteoclasts and osteoblasts (Raisz & Martin 1984, Chyun & Raisz 1984). The 
effects of parathyroid hormone (PTH) are modulated by IGF-I and CSF; the effects on 
bone metabolism are dependent on circulating PTH concentrations as well as on the time 
of exposure to excess PTH concentrations (McCarthy et a1 1997, Horowitz et a1 1988). 
Vitamin D is comprised of two substances, calcifediol (25-dihydroxyvitamin D) and 
calcitriol (1,25trihydroxyvitamin D). PTH is important for conversion of calcifediol to 
calcitriol (Schmidt-Gayk et a1 1997). Calcifediol and calcitriol are involved in maturation 
of osteoblasts as well as normal growth and inhibition of bone (Canalis 1990, Civitelli et 
a1 1990). Also, decreased concentrations of calcifediol and calcitriol are associated with 
increased BMU activation. 
Estrogen reportedly decreases production of the osteoid matrix, and appears to 
enhance the formation of trabecular bone (Takano-Yamamoto & Rodan 1990). The 
decrease in estrogen that occurs with menopause results in a decline in bone mass. 
Calcitonin is a calcitropic hormone that is an effective inhibitor of bone resorption 
(Gruber et a1 1984, Avioli 1982). Calcitonin inhibits osteoclast activity. Increased 
concentrations of thyroid hormone, either due to hyperthyroidism or from therapeutic 
administration of this hormone, cause increased bone turnover (Canalis 1993, Martin et a1 
1989). 
Bone resorption and formation require interaction between osteoblasts and 
osteoclasts. This interaction is regulated by hormones cytokines, especially IL-1 alpha 
and beta. Osteoblasts have receptors for IL-alpha, when activated they will stimulate 
osteoclasts. Osteoblasts presence is essential for osteoclasts IL-I mediated bone 
breakdown. At low levels IL-I beta stimulate bone formation, while at high 
concentrations it inhibits it (Canalis 1986, Mitchell et a1 1998). 
Markers of bone formation: 
Alkaline phosphatase (ALP) 
The exact function of this enzyme is unknown. It has broad tissue distribution and 
appears to be involved in the transport of substances from the intracellular compartment 
across the membrane to extracellular region (Christenson 1997). In bone, ALP may also 
be involved in the breakdown of pyrophosphate, a potent inhibitor of calcium phosphate 
deposition at the extracellular level (Risteli & Risteli 1993, Christenson 1997) 
Four ALP isoenzymes are commonly present in blood (Datta et a1 2008). These 
isoenzymes are relatively specific for the organs they represent which are; liver, bone, 
placenta, and intestine. The bone specific ALP isoenzyme (B-ALP) predominates during 
childhood and adolescence (Christenson 1 997). 
B-ALP is produced in extremely high amounts during the bone cycle's formation 
phase and is therefore, an excellent indicator of bone formation activity (Whyte 1983, 
Vanstraalen et a1 199 1, Christenson 1997).Evidence for B-ALP involvement in bone 
formation can be seen in patients with hypophosphatasia, a rare inherited autosomal 
recessive disorder characterized by defective mineralization of bone and teeth. The 
disease is diagnosed by deficient levels of total ALP (Gundberg 2000). 
Osteocalcin 
Osteocalcin is a vitamin K-dependent protein. It is only found in bone tissue and 
dentin. Osteocalcin is a peptide of 49 amino acids. It is assumed that much of the newly 
synthesized protein is incorporated into the bone matrix. Osteoclacin functions in binding 
calcium (Christenson 1997). The synthesis of osteocalcin in osteoblasts is controlled by 
calcitriol, 25-dihydroxyvitamin D, which activates its synthesis. Some of the newly 
synthesized osteocalcin is released into the circulation. The serum level of osteocalcin is 
a very specific marker for the rate of bone formation when formation and resorption are 
uncoupled. When resorption and formation are coupled, serum osteocalcin levels reflect 
bone turnover (Cornier 1995). 
Root End Filling Materials: 
The purpose of root end filling procedure is to seal the root canal system. The root 
end filling material must be stable and biocompatible. Root end filling material need to 
adhere to root structure, maintain hermetic seal, be insoluble in tissue fluids, 
dimensionally stable, non-resorbable, radiopaque, non-toxic, and be biocompatible with 
tooth and surrounding structures (Roberts et a1 2008). A variety of root end filling 
materials, GP, amalgam, cavit and zinc oxide eugenol based cement such as super EBA 
and IRM. A relatively recent root end filling material, Mineral trioxide aggregate (MTA) 
is now believed to be most biocompatible root end filling material and it is widely used in 
apical surgery, as well as perforation repair, direct pulp capping and apexification 
(Roberts et a1 2008). 
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MTA: 
MTA is a cement advocated for the dental use in peri-radicular surgeries, 
perforation repairs and as a pulp capping material. It is commercially available as 
ProRoot MTA (Tulsa Dental Products,Tulsa, OK, USA). MTA received FDA approval in 
1998 (Camilleri et a1 2006). MTA is available in the USA in two forms, grey MTA 
(GMTA) and white MTA (WMTA). In Brazil, MTA Angelus is also available in grey 
and white forms (Angelus Solucoes Odontologicas, Londrina, Brazil). 
MTA consists of 50-75% (wt) of calcium oxide and 15-25% silicon dioxide. 
When mixed they produce tricalcium silicate, dicalcium silicate, tricalcium aluminate and 
tetracalcium aluminoferrite (Torabinejad & White 1995, Torabinejad & Hong 1995, 
Camilleri et a1 2006). However, in a recent review by Roberts et a1 (2008), several studies 
reported MTA to consist of, dicalcium silicate, tricalcium silicate, tricalcium aluminate, 
tricalcium aluminoferrite, gypsum and bismuth oxide. MTA also contains trace amounts 
of silicon oxide (Si02), calcium oxide (CaO), magnesium oxide (MgO), potassium sulfate 
(K2SO4), and sodium sulfate (Na2S04). 
Compared to Portland cement, MTA has less gypsum than portland cement. 
Bismuth oxide is added to MTA for radio-opacity. MTA also has a smaller mean particle 
size, fewer heavy metals and longer setting time, when compared to Portland cement 
(Roberts et a1 2008). 
GMTA is a grey powder which is mixed with sterile water in a 3:l (w/v) ratio 
according to manufacturer's instruction. Setting time of GMTA is between 3-4 hours 
(Roberts et a1 2008, Dammaschke et a1 2005, Torabinejad et a1 1995). It sets in a 
hydration reaction of tricalcium silicate (3Ca0.Si02) and dicalcium silicate (2CaO-Si02). 
Upon mixing it forms a colloidal gel, which solidifies into a hard structure in the presence 
of moisture (Roberts et a1 2008). In apical surgery applications moisture is provided from 
surrounding tissues. The pH of setting MTA rises from 10.2 to 12.5 three hours after 
mixing (Torabinejad & Pitt Ford 1995, Carnilleri et a1 2006). 
In 2002, white MTA (WMTA) was introduced by Dentsply Endodontics, Tulsa, 
OK, USA. Asgary et a1 (2005) characterized the differences between GMTA and WMTA 
using SEM and probe microanalysis. WMTA was found to have 54.9% less 
A12 03,  56.5% less MgO, and 90.8% less FeO than GMTA. The author concluded that 
reduced ferrous oxide concentration is most likely the cause for the white color of 
WMTA. 
Song et a1 (2006) compared the chemical and crystalline composition of Portland 
cement, ProRoot GMTA, ProRoot WMTA, and gray MTA-Angelus. The author used X- 
ray diffraction analysis, and energy dispersive x-ray spectrometry of both freshly mixed 
and set materials. The author found the crystalline structure and chemical composition of 
GMTA and WMTA were similar except for the presence of iron in GMTA, which was 
different from findings of Asgary et a1 (2005). Both were composed mainly of bismuth 
oxide and calcium silicate oxide. Portland cement was composed mainly of calcium 
silicate oxide and had no bismuth oxide. Gray MTA-Angelus had a lower content of 
bismuth oxide than ProRoot MTA. The author found no noticeable differences in the 
chemical composition and crystalline structures between the powder and set forms of any 
of the material tested. 
Biocompatibility : 
The biocompatibility of new dental materials is established in vivo and in vitro 
methods to evaluate interactions between host and material. MTA has undergone 
different types of investigation, usage tests, implantation, cells attachment and 
cytotoxicity tests. MTA was found to be biocompatible; it also induces osteogenesis and 
cementogenesis. MTA effectively seal root and furcal perforations and apical foramina. 
Studies In Vivo: 
Torabinejad et a1 (1 995) examined the periradicular tissue response of dog's teeth 
with apical periodontitis to GMTA and amalgam. Forty six roots in six beagle dogs were 
used and periradicular tissue lesions were developed. The canals on half of the roots were 
instrumented and obturated with gutta-percha and sealer, and their access cavities were 
sealed with GMTA. The remaining root canals were instrumented and obturated with 
gutta-percha without root canal sealer, and their access was left open. After 2 weeks, 
roots were resected; half of the root-end cavities were filled with amalgam and the rest 
with GMTA. The periradicular tissue response of the dogs was evaluated histologically at 
2 to 5 and 10 to 18 wks following periradicular surgery. The results showed less 
periradicular inflammation and more fibrous capsules adjacent to GMTA, compared with 
amalgam. In addition, the presence of cementum on the surface of GMTA was a frequent 
finding. 
In a similar study, Bernabe et a1 (2007) compared GMTA to zinc oxide eugenol 
cement (ZoE). Histological examination was done after 180 days. Results showed 
cementum deposited only over GMTA. ZoE showed severe inflammation compared to 
GMTA. No bacteria were found at the interface between both materials and dentin. The 
author proposes that MTA antibacterial properties are due to formation of calcium 
hydroxide from reaction of calcium oxide with water. In another dog study, Baek et a1 
(2005) using 24 roots compared the periapical tissue reaction, as well as cementum 
regeneration in contact with amalgam, Super EBA, and GMTA using undecalcified 
ground sections. Five months after periapical surgery, GMTA showed minor 
inflammatory reaction with plasma cells, lymphocytes and some macrophages. 
Cementum deposition occurred on the GMTA surface. The author speculated that new 
cementum formation could have originated from periodontal ligament and bone cells. 
To observe the healing process with GMTA repaired root canal perforation: 
Holland et a1 (2001) created lateral root perforation in 48 root canals of dog's teeth after 
complete instrumentation. The perforations were repaired with GMTA, and Sealapex was 
used as a control. At 30 and 180 days histological analysis was done. Results showed no 
inflammation and cementum deposition around MTA, while Sealapex was surrounded 
with chronic inflammation and slight deposition of cementum. 
Furcation repair was studied by Yildirm et a1 (2005). Furcal perforations were 
created in 90 mandibular premolars and molars in 9 mongrel dogs. Seventy two teeth 
were repaired with GMTA or Super EBA and 18 without repair served as negative 
controls. Histological examination was done at 1, 3, and 6 months. GMTA showed mild 
inflammation at 1 month, which decreased at 3 months and diminished at 6 months. 
Cementum deposition was found on all GMTA specimens at 6 months. 
Regan et a1 (2002) compared periapical tissue reaction to GMTA and Diaket. The 
experiment was similar to Torabinejad et a1 (1995), however no lesions were developed 
in the periapical tissues. Two months after surgery, histological sections were compared 
according to detailed criteria. The results showed no difference between GMTA and 
Diaket in the presence of inflammation and bone formation. New periodontal ligament 
formation was greater on the Diaket surface compared to GMTA. Cementum coverage 
was not complete but, variable and unpredictable on both materials. 
In a retrospective human study, Main et a1 (2004) looked at all repaired root 
perforations completed in the University of Loma Linda endodontic residency program. 
Only GMTA repaired perforations with radiographs and a minimum of 1 year recall were 
included. Only 16 patients met the criteria, 5 were strip perforations, 5 laterals, 3 furcal, 
and 3 apical perforations. All cases had preoperative radiolucency that decreased in size 
at 1 year recall. 
In conclusion, the reviewed studies support the biocompatibility of GMTA when 
it's in contact with periapical tissue. Also these studies show GMTA to be more 
biocompatible when compared with other commonly used dental materials. 
Studies In Vitro: 
Periodontal ligament cells: 
Several studies looked at the cytotoxicity, attachment and cytokines production of 
periodontal ligament cells when in contact with MTA. Thomson et a1 (2003) investigated 
the effects of GMTA, IRM, and amalgam on murine cementoblast growth, in tissue 
culture. Cells and materials were incubated for 48 h then fixed for scanning electron 
microscopic analysis. Gene expression was evaluated on GMTA and IRM using reverse 
transcriptase polymerase chain reaction (RT-PCR) with primer sets for glyceraldehyde-3- 
phosphate dehydrogenase, type I collagen, alkaline phosphatase, osteocalcin, and bone 
sialoprotein after 3 and 5 days. The presence of osteocalcin on GMTA was evaluated 
using conofocal microscopy after 7 and 12 days of incubation. Images were compared 
with controls to assess qualitative differences. Results showed better cell attachment on 
GMTA compared to IRM and amalgam. RT-PCR results were not conclusive; IRM did 
not yield enough products for PCR use. However, GMTA results were similar to control. 
Osteocalcin production increased from 5 to 12 days in GMTA and control. The author 
concluded that GMTA is cemento-inductive by allowing the expression of genes and 
proteins involved in the cementogenesis process. 
The attachment and morphology of human periodontal ligament fibroblasts on 
GMTA was evaluated using a scanning electron microscope (Balto et a1 2004). GMTA 
was placed in an apical cavity of 30 single-rooted slices of extracted human teeth, which 
were divided in 2 groups freshly prepared and set, as well as 2 control slices. A 
suspension of human periodontal ligament fibroblast cells was placed over the MTA 
filling and control. In the set-MTA group, cells were round and flattened, displayed 
smooth surfaces, and appeared to be tightly attached to MTA. In the freshly mixed state 
cells did not show attachment. 
Vajrabhaya et a1 (2006) evaluated the cytotoxicity of furcal perforation repair 
materials, Ketac molar, glass ionomer and GMTA, using cell culture technique. The 
extract of GMTA and Ketac Molar were added on PDL cells in tissue-culture plates. Cell 
proliferation after an incubation period of 3 days was determined by using the MTT 
assay. The growth of cultured human periodontal fibroblast cells were suppressed by both 
materials, However the GMTA group showed more viable cells. 
The cytotoxicity of amalgam, glass-ionomer, SuperEBA, N-Rickert, GMTA and 
gutta-percha cytotoxicity was compared against permanent V79 fibroblasts and murine 
granulocyte-macrophage progenitor cells (Souza et a1 2006). Eluates from the materials, 
using extraction medium were added to the culture medium for 72 h and their 
cytotoxicities were assessed over 24 h and 7 days. Cytotoxicity was judged using the total 
nucleic acid content (NAC), neutral red uptake (NRU) and reduction of the tetrazolium 
salt (MTT). GMTA was ranked as the least cytotoxic cement in both cell systems. 
Gorduysus et a1 (2007) compared the cytotoxicity, induced apoptosis and/or necrosis, and 
apoptotic mechanisms in human periodontal ligament (PDL) fibroblasts treated with four 
different endodontic materials: ProRoot (WMTA), Diaket, Endion, and CYMED 8410. 
The effects of these four materials on the viability of PDL fibroblasts were determined by 
MTT (3-(4,5-dimethyl-thiazoyl)-2,5-diphenyl-SH-tetrazolium bromide) assay. Apoptotic 
pathways were evaluated via Annexin-VIP1 double-staining Assay, and cell cycle 
analysis. Exposure to WMTA for 24, 48, and 72 hours resulted in no significant 
differences in MTT reduction and viable cell numbers comparable to controls. However, 
treatment of PDL fibroblasts with Diaket, Endion, and CYMED 8410 resulted in a 
reduction of viable cell number compared with controls. Annexin VIP1 staining and cell 
cycle analysis showed that Diaket, Endion, and CYMED 8410 induced higher 
percentages of apoptosis and/or necrosis than in controls. The results suggest that WMTA 
is a less damaging material. 
BMP-2 induces bone, cartilage, cementum and dentin formation, while TGF beta- 
1 has been shown to inhibit or stimulate bone formation and thought to block the effect of 
BMP-2 on bone cells. Guven et a1 (2007) compared the effects of ProRoot GMTA and 
grey MTA Angelus on transforming growth factor (TGF)-beta1 and bone morphogenetic 
protein (BMP)-2 levels produced by cultured human gingival fibroblasts (HGFs). After 
24 and 72 hours of exposure to the MTA products, HGF viability was determined by 
using the MTT assay. TGF-beta1 and BMP-2 levels in cell-free culture media were 
determined by enzyme-linked immunosorbent assay. Cell viability of the test groups was 
significantly lower than that of control at 24 and 72 hours but showed an increase at 72 
hours. MTA Angelus group displayed higher TGF beta-1 levels than control and ProRoot 
MTA groups at 24 and 72 hours. BMP-2 levels of both test materials were similar at 24 
and 72 hours. These results suggest that both MTA products are capable of stimulating 
HGF to produce BMP-2, whereas the stimulatory effect for TGF beta-1 is material 
dependent. Although both BMP-2 and TGF beta-1 were increased, the inhibitory effect 
could not be detected. 
Osteoblast cells: 
The reaction of osteoblasts to MTA was first tested by Koh et a1 (1997). The 
materials and methods were repeated by many researchers. In his study Koh et a1 (1 997) 
used osteoblasts (MG-63) derived from human osteosarcoma. GMTA (Loma Linda) and 
polymethylmethacrylate commonly used orthopedic cement, were tested in both the 
freshly prepared and set state. Cells were grown in presence of materials and tested over 
1 - 144hrs period. Standard ELISA assays were used for assessment of interleukin (1L)- 1 
alpha, IL-1 beta, IL-6, macrophage colony stimulating factor (M-CSF), and osteocalcin. 
In brief, the assays employ a "sandwich" enzyme immunoassay technique which was 
used per the manufacturer's instructions. A color develops, the intensity of which is in 
proportion to the amount of cytokine present, and it then is measured and compared with 
known standards prepared from doubling dilutions. The samples were read at 450 nrn 
with a correction at 570 nm using a spectrophotometer. The levels of alkaline 
phosphatase were measured to establish the level of differentiation of the cells. 
Cells were collected and assayed using the Sigma protocol for alkaline 
phosphatase activity. Following the periods of growth, the cells were washed and three 
times with phosphate-buffered saline and by three cycles of freezing and thawing. The 
basis the assay was to utilize a 2-amino-2-methyl-1-propanol buffer with an incubation 
period of 15 min (Sigma, Procedure 104). The reaction was stopped with 10 mL of 0.05 
NaOH, and the color, generated by the presence of p-nitrophenol, was measured by 
absorbance at 400-420 nm. In all dishes cells were seen adhering to the base and GMTA 
at 6 h and had increased to confluence at 144 h. IL-1 alpha, IL-1 beta, and IL-6 were 
raised when the cells were grown in the presence of GMTA at 144 h. M-CSF appeared to 
be unaffected although the overall value was high. Cells grown with PMA produced 
negligible levels of cytokines. Osteocalcin production increased when cells were grown 
on GMTA. No osteocalcin could be detected with PMA. Cells in contact with GMTA 
also appeared to have higher levels of alkaline phosphatase. No cells could be found 
attached to PMA and so no alkaline phosphatase activity could be measured. 
In another study involving osteoblasts, Koh et a1 (1998) used the same materials 
and methods to test the morphology of osteoblasts (MG-63) when grown with GMTA 
and IRM. SEM analysis revealed healthy cells in contact with GMTA at 1 and 3 days; in 
contrast, cells in the presence of IRM appeared rounded. The ELISA assays revealed 
raised levels of all tested cytokines at all periods when cells were grown in the presence 
of GMTA; in contrast, cells grown alone or with IRM produced undetectable amounts. 
The M-CSF was produced by cells irrespective of the group. The author concluded that 
GMTA offers a biologically active substrate for bone cells and stimulates IL production. 
Mitchell & Pitt ford (1999) carried out the same experiment using a variant of 
GMTA. The authors did not specify the changes they made to GMTA; however their 
results were in agreement with Koh et a1 (1997 and 1998). Nakayama et a1 (2005) used 
bone cells from rat femur without specifying the cell line he used. Materials used were 
GMTA and IRM. Cells were then seeded on three dishes of each material, and cultured 
for 3 days, and then evaluated using SEM and transmission (TEM) electron microscopy. 
The calcium released from hydrated material, the cell proliferation ratio and alkaline 
phosphatase (ALP) activity were analyzed, and the expression of type I collagen and 
bone-related protein mRNAs were evaluated using RT-PCR. In the GMTA group, SEM 
and TEM showed that the cells attached in the same manner as the control group. The 
calcium released and ALP activity was similar to the control group. Cell proliferation and 
expression of type I collagen mRNA was significantly lower, while the expression of 
osteopontin mRNA was significantly higher than the control group at the third day of 
culture. In IRM groups, a few rounded cells were observed on the material but no living 
cells were seen. The author concluded that GMTA is a material of low toxicity which 
does not inhibit cell growth, but does suppress the differentiation of osteoblast-like cells. 
Zhu et a1 (2000) compared the attachment of human osteoblast -like-Saos-2 cells 
to GMTA, IRM, composite and amalgam. Materials were condensed into bottoms of a 96 
-well culture dish using an amalgam to make 1 mm thick disks, then cells and culture 
medium were added and incubated for 2 weeks. SEM observation showed that 
osteoblasts attached and spread on GMTA and composite by forming a monolayer. 
Osteoblasts also attached on amalgam, but with few cells spreading. In the presence of 
IRM, osteoblasts appeared rounded with no spreading. 
Tani-Ishii et a1 (2007) grew MC3T3-El cells with GMTA, amalgam and Dycal. 
RT-PCR with primer sets for type I collagen, osteocalcin, and bone sialoprotein was used 
to measure the gene-expression response of the cells with the tested materials. GMTA 
caused an up-regulation of type I collagen and osteocalcin messenger RNA expression 
after 24 hours. In a similar study using the same cell line, Yoshimine et a1 (2007) 
compared the cell response to GMTA, IRM and 4-METNMMA-TBB resin. The results 
showed better attachment of cells to GMTA compared to other materials. 
Al-Rabeah et a1 (2007) analyzed the response of human alveolar bone cells to 
GMTA and WMTA. Cells were grown from human alveolar bone explants. The author 
did not specify the cell line obtained. Cells were seeded onto set ProRoot GMTA, 
WMTA, and MTA prepared with local anesthetic solution, instead of water. SEM 
showed cells were attached and spread out on all materials within 24 hours, and 
proliferated to form a matrix-like layer within 7 days. Cell attachment and cell-surface 
interactions with all materials were similar. 
Camilleri et a1 (2004) examined the biocompatibility of Pro Root GMTA and 
WMTA when grown with Saos-2 osteosarcoma cells. Both materials were placed on 
glass cover slips and allowed to set for 1 or 28 days. Saos-2 osteosarcoma cells were 
seeded and placed in medium over the material-coated coverslips for 1, 5 and 7 days. Cell 
morphological changes were evaluated by SEM. The response to both materials was 
similar. The 1-day cured samples of two commercial forms of MTA showed good 
biocompatibility. However, the 28-day cured samples were less biocompatible after 1 and 
5 days. The author believes the biocompatibility of the 1 day mixed material due to 
calcium hydroxide production. The setting reaction of MTA yields Ca (OH)z from 
tricalcium silicate. Free tricalcium silicate was not available once all material was fully 
set after 28 days. 
In a similar study, Perez et a1 (2003) tested the same materials against primary 
osteoblasts and MG-63 osteosarcoma cells. The cells were exposed to beta- 
glycerophosphate and dexamethasone to assess mineralized nodule formation as a 
function of osteogenic behavior. The results showed the number of cells on the surface of 
the materials increased in all samples throughout the experiment, except for WMTA 
where no primary osteoblasts were visible on top of the material by the end of 13 days. 
After exposing cells to differentiation medium, nodules were observed in cultures of 
primary osteoblasts, but not of MG-63 osteosarcoma cells. MG-63 cells do not behave 
osteogenically by forming mineralized nodules, and primary osteoblasts are more 
sensitive than MG-63 osteosarcoma cells to WMTA in cell culture. The author 
recommended primary osteoblasts for testing endodontic materials in cell culture. 
MTA mixed with water has a short working time, delayed setting, and poor consistency. 
Recently, research was focused on obtaining an alternative delivery vehicle for MTA, to 
improve its setting time and handling characteristics. 
Improving MTA Properties: 
Many clinicians subjectively report that the handling properties of MTA are less 
than ideal. The consistency is difficult to maintain due to the setting reaction that results 
in desiccation of the MTNwater mixture .Long setting time of MTA makes it less than 
ideal for apexification and perforation repair. Several researchers worked on improving 
the handling characteristics of MTA. 
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Wiltbank et a1 (2007) added Portland cement (PC) accelerators (calcium chloride 
CaC12, calcium nitritelnitrate, and calcium formate) to GMTA, WMTA and PC. Initial 
setting time, dimensional stability, temperature during set, and pH were measured. It was 
found that all 3 additives significantly accelerated the setting of GMTA and PC; only 
calcium chloride and calcium formate significantly accelerated WMTA. Dimensional 
stability was not significantly different between control and experimental groups. 
Calcium chloride decreased the pH of GMTA and PC, while pH increased with calcium 
nitritelnitrate and calcium formate. The author concluded that further studies are needed 
to evaluate the biocompatibility of these additives to MTA. 
In a similar study, Ber et a1 (2007) added the following accelerants 2% CaC12 to 
1%, 2%, and 3% methylcellulose (MC), to GMTA powder. Those three different 
mixtures were then added to GMTA and PC. One percent of MC and 2% of CaC12 added 
to GMTA resulted in a mixture that handled similarly to a reinforced zinc oxide-eugenol 
cement. The mixture gave an approximately equal compressive strength, and set three 
times faster (57 +I- 3 minutes) compared to 3-4 hours for regular GMTA. 
Karimjee et a1 (2006) compared the biocompatibility of WMTA mixed with water 
or with KY Jelly (Johnson & Johnson, New Brunswick, NJ) to that of Fuji I1 LC (GC 
America, Alsip, IL), cement and amalgam. Periodontal ligament (PDL) cells were 
cultured. Eluates from mixed materials were placed in contact with the PDL cells for 24, 
48, and 72 hours. Cell viability was determined by measuring mitochondria1 enzyme 
activity using the MTT assay. Cytotoxicity was also measured in terms of cell lysis using 
the lactate dehydrogenase assay. One mL a-minimum essential medium (a-MEM) 
(Gibco, Grand Island, NY) supplemented with 100 pglmL penicillin G (Sigma Chemical 
Co., St. Louis, MO), 50 pg/mL of streptomycin (Sigma), and 0.2% fetal bovine serum 
(FBS; Hyclone, Logan, UT) was added to test material, and then eluates were extracted. 
Eluate extractions from all materials caused significantly less cell viability and more cell 
death than control at all times. However, at 72 h the WMTNwater, WMTAIKY, and 
amalgam eluate extractions led to significantly better cell viability than the Fuji I1 eluates. 
The author concluded that WMTNKY, WMTA/water, and amalgam have similar 
biocompatibility regarding effects of their eluates on human PDL cells. 
Kogan et a1 (2006) added several additives to MTA to enhance its setting 
properties. Additives tested included saline, 2% lidocaine, 3.0% NaOCl gel, 
Chlorhexidine gulconate gel, KY Jelly, 3% and 5% CaC12. The setting times were 
evaluated using Vicat apparatus. Compressive strength of the set materials was evaluated 
using an Instron machine. NaOCl , KY jelly and CaC12 decreased the setting time to 20- 
25 minutes. Compressive strengths of these materials were lower than MTA mixed with 
water. The author found NaOCl, KY jelly, and CaC12 had improved handling properties. 
The author also recommended these materials to be mixed with MTA, when root canal 
system obturation and MTA repair are to be done in one visit. 
There are numerous studies of the biological properties of GMTA and WMTA 
(Roberts et a1 2008). Studies In vitro of cell attachments and morphology, cytokine 
production, and cytotoxicity have been well documented (Roberts et a1 2008, Beranbe et 
a1 2007, Baek et a1 2005, Thomson et a1 2003, Balto et a1 2004, Souza et a1 2006, 
Gorduysus et a1 2007, Guven et a1 2007, Koh et a1 1997 and 1998, Zhu et a1 2000). These 
materials are also osteoconductive. However, substantially no information is available on 
how these new chemical additives changes the biological properties of the grey and 
white.MTA formulations. This appears especially important as the biological effects of 
MTA are related to biochemical interactions between tissues and the surface of the 
material. 
Therefore, this study was designed to add KY, NaOCl and 5% CaC12 to grey 
MTA and investigate the biological effects of adding several additives to GMTA. 
Aims of this study: 
The aims of this study were to: 
1) Compare the pH, temperature, and setting time of the following additives; KY liquid, 
Calcium Chloride (CaC12), and Sodium Hypochloride gel to GMTA mixed with water 
(Part 1). 
2) Compare the cell attachment to test materials using fluorescent microscope (Part 2). 
3) Compare the cell attachment to dentin and test materials using fluorescent microscope 
(Part 3). 
4) Measure levels of the following bone formation markers: TNF-Alpha (TNF-a), 
interleukin- 1 alpha (IL- 1 a), interleukin- 1 beta (IL- 1 P), and macrophage colony 
stimulating factor (M-CSF), (Part 4). 
Materials and Methods: 
All experiments were performed in triplicates. Materials were divided into the 
following groups. Group 1 (control): GMTA mixed with sterile water in 3: 1 (wlv) ratio. 
Group 2 (test): GMTA mixed with 5% calcium chloride CaC12 (Sigma-Aldrich, St. Louis, 
MO). Group 3 (test): GMTA mixed with KY liquid (Johnson & Johnson, Langhorne, 
PA). Group 4 (test): GMTA mixed with sodium hypochloride (NaOC12) gel (ChlorCid V, 
Ultradent Products. Inc, South Jordan, UT). 
Part 1: 
Temperature and pH measurement: 
Test and control materials were mixed using 0.5 g of grey MTA in 3: 1 ratio (wlw) 
o Group 1 : Grey MTA with water ( positive control) 
o Group 2:KY liquid 
o Group 3: Calcium Chloride (CaC12) 
o Group 4: Sodium Hypochloride gel (NaOC1) 
Calibrated pH probe (HANNAA pH21, pH/mV; HANNA instruments, Woonsocket, 
RI),Figure 1, was introduced to each group. The probe was calibrated after each reading. 
Readings were taken immediately after mixing and every 5 minutes for 15 minutes. 
Setting time: 
Test and control materials were mixed; 1 full GMTA pack was mixed for each group and 
was placed in one well of a 24 well culture plate (Costar, Corning, NY). During the 
experiment, samples were covered with deionized water moistened gauze and placed in a 
37°C incubator. The samples were tested just before their anticipated setting time and at 5 
minutes interval until fully set. A Gilmore apparatus, Fig 2, was used with a stainless 
steel indenter with 100-g mass applied at a right angle to the surface of the sample for 5 
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seconds. Setting time was defined as the length of time the indenter failed to leave a 
definite mark at the surface of the sample. 
Part 2: 
Osteoblasts: 
Mouse MC3T3-El osteoblasts were grown in Dulbecco's Alpha Modified Eagle 
Medium (DMEM-Alpha; Gibco BRL, Gaithersburg, MD) supplemented with L- 
glutamine ,ribonucleosides, deoxyribonucleosides, 10% fetal bovine serum (FBS; 
Hyclone laboratories, Logan ,UT) sodium pyruvate, glucose , and 1% of antibiotic1 
antimycotic cocktail (300 UlmL penicillin, 300 pg1mL streptomycin, 5 pg1mL 
amphotericin B). Cells were incubated at 37OC, 100% humidity, 95% air and 5% C02. 
Material disks: 
Part 1 control and test materials were used to make uniform disks, using 
orthodontic elastic bands (6mm wide x 1.5mm deep). Disks were covered with deionized 
water moistened gauze until fully set. Amalgam Valiant PH.D.( Ivovlar Vivadent, 
Amherst, NY) IRM caps (Dentsply Caulk, Milford, DE), and composite 340 A4 Tetric 
Flow Ivovlar Vivadent, Amherst, NY), served as negative controls. Three disks of each 
were made. After setting all disks were smoothed and polished using carbide bur (Alpine, 
FG 7664, Coltenelwhaledent. Germany). 
Cell attachment: 
Six disks of each group were placed in the bottom of 12-well cell culture plates 
(Costar, Corning, NY) as shown in Fig 3. Cells with medium were added to the wells and 
incubated for 4 days under 37OC, 100% humidity, 95% air and 5% C02. At day land 4 
days, 3 samples of each group were removed and washed twice with phosphate- buffered 
saline. 
Fluorescent Microscope: 
The protocol was adapted from Jiang et a1 (2003).Specimens were fixed for 15 
minutes at room temperature with 2% paraformaldehyde, washed with phosphate 
buffered saline, and treated for 20 minutes with 0.2% Triton X-100 solution (Sigma, St. 
Louis, MO) to permeabilize cell membranes. For the identification of F-actin, the cells 
were incubated with 1 pg/mL of flourescein isothiocyanate-conjugated phalloidin (Sigma) 
for 20 minutes at room temperature. For the identification of nuclei, the cells were stained 
with lOpg /ml of Hoechst 33342 for 20 minutes. All specimens were washed with 
phosphate- buffered saline, and the distribution of the actin ring was determined using 
fluorescence microscopy (Ziess observer Zl),  shown in figure 4. 
Part 3: 
Dentin disks: 
Caries free freshly extracted single rooted teeth were collected. Roots were 
scraped with surgical blade to remove periodontal ligament cells. Crown and apical 3 mm 
were removed using high speed hand piece with straight fissure carbide bur (Midwest, 
FG #57, Dentsply, York, PA) under water spray. Longitudinal buccal and lingual grooves 
were created and teeth were split into 2 halves using straight fissure carbide bur 
(Midwest, FG #57, Dentsply, York, PA). Each half was cut in the middle to create 
roughly 6x6mm dentin disks using the same bur. Class I cavity measuring roughly 
3x3x3mm were created using high speed hand piece with water and straight fissure 
carbide bur (Midwest, FG #57, Dentsply, York, PA). Disks were stored in saline 
supplemented with 1 % antibiotic1antimycotic cocktail (300 unitslml penicillin, 300 pglml 
streptomycin, 5 pglml amphotericin B (Gibco BRL, Gaithersburg, MD). 
Test materials: 
Negative, positive controls, and test materials in part 1 were mixed and placed in 
cavities using amalgam carrier and condenser. Disks were placed in 12-well cell culture 
plates (Costar, Coming, NY) with storage medium for 24 hrs until set (Fig 6). Disk 
surfaces were smoothed and polished using a high speed hand piece with carbide bur 
(Alpine, FG 7664, Coltenelwhaledent. Germany) under water spray. 
Cell attachment: 
Two cell lines were used. Mouse MC3T3-El osteoblasts were grown in 
Dulbecco's Alpha Modified Eagle Medium (DMEM-Alpha; Gibco BRL, Gaithersburg, 
MD) supplemented with L-glutamine ,ribonucleosides, deoxyribonucleosides, 10% fetal 
bovine serum (FBS; Hyclone laboratories, Logan ,UT) sodium pyruvate, glucose , and 
1% of antibiotic1 antimycotic cocktail (300 UImL penicillin, 300 pg1mL streptomycin, 5 
pg1mL amphotericin B). Cells were incubated at 37OC, 100% humidity, 95% air and 5% 
c o 2 .  
L929 mouse fibroblasts were obtained from American Type Culture Collection 
(ATCC, Manassas, VA). Cells were grown in Eagle's minimum essential medium 
(EMEM, ATCC) supplemented with 10% fetal bovine serum (FBS, Hyclone 
Laboratories, Inc., Logan, UT) and 1% antibioticlantimycotic cocktail (300 units1mL 
penicillin, 300 mg1mL streptomycin, 5 mg/mL amphotericin B; Gibco BRL, 
Gaithersburg, MD) under standard cell culture conditions (37"C, 100% humidity, 95% air 
and 5% COz). 
Disks placed in 12-well cell culture plates (Costar, Corning, NY). Cells and 
culture mediums were added to disks at lo5/ well and incubated for 24 hrs under standard 
cell culture conditions (37 OC, 100% humidity, 95% air and 5% C02). Disks were 
prepared for fluorescent microscope as previously mentioned. 
10 additional disks of the test materials and controls in part 2 were made. 
Mouse Macrophages: 
The mouse macrophage cell line RAW 264.7 was obtained from American Type 
Culture Collection (ATCC, Manassas, VA). Cells were grown in Eagle's minimum 
essential medium (ATCC) supplemented with 10% fetal bovine serum (Hyclone 
Laboratories Inc. Logan UT) and 1% antibiotic/antimycotic cocktail (300 unitslml 
penicillin, 300 pglml streptomycin, 5 pglml amphotericin B (Gibco BRL, Gaithersburg, 
MD) under standard cell culture conditions (37 OC, 100% humidity, 95% air and 5% 
C02). 
After MTA disks were placed into the 12-well cell culture plates (Costar, 
Coming, NY), cells were seeded at a density of 10~lwell in DMEM with 10% fetal 
bovine serum. After 3-day incubation, culture medium was collected. The following 
bioactive molecules were measured by use of a commercially available sandwich ELISA 
kit (R&D System, Minneapolis, MN, USA): 
o Macrophage colony stimulating factor (M-CSF): 
o Interleukin-1 alpha (IL- 1 a )  
o Interleukin- 1 beta (IL- 1 P) 
o Tumor necrosis factor alpha (TNF-a) 
Interleukin 1 Alpha (IL-la), Interlukin-1-Beta (IL-lp), Tumor necrosis factor- 
Alpha (TNF-a), and Macrophage colony stimulating factor (M-CSF): 
The Koh (1998) protocol was followed. One mL of media was removed from 
wells of each group at day 3; and stored at -20°C until required. The assay used a 
quantitative "sandwich" technique (Quantikine R&D Systems, Oxford, UK). The 
microtitre plate had a monoclonal antibody specific to the interleukin (IL) being 
investigated that was coated in each well. Control and samples were placed in wells and 
any cytokine present bound to the immobilized antibody. After several washes, 
polyclonal enzyme-linked antibodies were then placed in the wells. Unbound polyclonal 
antibodies were then washed off and a substrate added. A yellow color developed, and 
the intensity, which was proportional to the amount of cytokine present, was then 
measured. A spectrophotometer set at 450 nm was used to measure the optical density of 
each well. 
Statistical Analysis: 
Results from cytokine tests were analyzed via one-way ANOVA and student t-test. 
Results: 
Part 1: 
The pH and setting time of each group are shown in Tables 1, 2 and 3.This table 
shows a gradual increase in pH in the control and KY group over the 15 minute period. 
While all other groups showed gradual decrease in pH over the same period. KY had 
lower pH values at 0, 10, andl5 minutes which was statistically significant when 
compared to control. CaC12 at 9 minutes had pH of 10.49 which was statistically 
significant when compared to control. NaOCl had lower pH than control which was 
statistically significant at 5 and 15 minutes. 
Temperature in all four groups remained relatively constant in all test groups, 
while control showed gradual decrease between 0-15 minutes. KY and NaOCl were 
lower than control at 0 minutes, which was statistically significant. 
This table shows the KY group with the shortest setting time of 70 minutes. The 
Control group had the longest time. NaOCl and CaC12 setting time was on average 60 
minutes less than control. Both KY and CaC12 showed statistically significant difference 
when compared to control group. 
Part 2: 
Cell attachment: 
All groups showed cell attachment after 1 day (Image l).Group 3 (CaC12) had 
fewer cells attaching to the surface compared to the remaining groups. At day 4 the 
growth and attachment of cells in all groups was extensive (Image 2). No differences in 
cell attachment were noted. 
Image 3 shows the control disks at day 1. Cells attached and spread on GMTA 
with water as well as composite. Limited number of cells attached to amalgam and IRM. 
Cells were rounded and showed no spreading. Similar results were obtained at day 4. 
Part 3: 
Mouse osteoblasts attached to dentin and cement in all groups. Cells spread from 
dentin into the cement surface. Image 4, shows spread of cells at the junction of cement 
and dentine in all four groups. There was no difference in the quantity of cells attached in 
all four groups. Similar results were obtained when mouse fibroblasts were seeded on 
cement surface (Image 5). Both image 4 and 5 show nuclei and cytoplasm of cells. Due to 
different thickness between dentine and cement images could not be digitally enhanced to 
show cytoplasm in some of the test groups. 
Image 6 shows osteoblasts cells attachment to GMTA and water as well as 
composite. Cells did not attach to IRM. Few cells attached to amalgam. Cells were 
rounded and showed no spreading. Fibroblasts showed similar results (Image 7). 
Part 4: 
IL-1 Alpha (LL-la), IL-1-Beta (IL-lp), TNF-Alpha (TNF-a), and Macrophage 
colony stimulating factor (M-CSF): 
TNF-alpha was released when cells were cultured with all groups. Compared 
with control group, there were significantly increased release of TNF- from NaOCl group 
(p<0.05) and significantly less release from KY group (p<0.05) (Fig. 7). 
There were no detectable changes for Interleukin- 1 alpha (IL- 1 a), Interleukin-1 
beta (IL-IP), and Macrophage colony stimulating factor (M-CSF) when cells were 
cultured with the various MTA disks. 
Discussion: 
The pH of the test groups was different fiom the control group. The control 
group pH on average increased from 9.88 immediately after mixing to 10.35 fifteen 
minutes after mixing. The NaOCl group showed reduction fiom 9.42 at 0 minutes to 8.87 
at 15 minutes, which was statistically significant at 5 and 15 minutes. This can be 
explained by the low pH of NaOCl itself. The CaClz group started with 10.49 at 0 
minutes, which was statistically significant when compared to control, and the pH 
decreased to 10.22 at 15 minutes, the final pH was similar to control. 
For the KY group the pH showed the greatest change from 7.68 at 0 minutes to 
9.89 at 10 minutes, then dropping back to 9.15 at 15 minutes. KY groups showed 
statistical significance at all time expect for 5 minutes period. Torabinejad et a1 (1999) 
showed that commercial MTA has a pH of 12.5. It has also been assumed that the high 
pH of MTA is responsible for its biological activity and the formation of a calcium 
hydroxide layer (Roberts et a1 2008, Camilleri et a1 2004). 
Wiltbank et a1 (2007) measured pH using the same protocol. pH was measured 
from 1-10 minutes. In his study, KY and NaOCl gels were not used. The pH of control 
and CaC12 were higher than our results, measuring 11.75 and 11.50, respectively. 
Measurements were presented on a graph instead of tables. In our results a drop in pH 
was noted toward the 15 minute period with all test groups. The pH of all groups did 
change with time. Increasing the time interval might yield different results. 
We have noted great difficulty in measuring the pH for all the test groups. 
Separate probes were used for each group and they were calibrated with a standard 
solution before each measurement was undertaken. However, it took longer for the pH 
reader to get a stable reading once the probe was placed in the cement. This can be due 
to the small amount of cement used. Increasing the amount of MTA and the time 
interval might give more consistent results similar to Torabinejad et a1 (1999). Due to 
the high cost of GMTA large amounts could not be experimented. However, a pilot can 
be done using Portland cement to specify the amount and time needed before carrying 
the final experiment. 
Temperature also changed slightly between 0 minutes and 15 minutes in all 
groups. Only KY and NaOCl at 0 minutes had lower temperatures than control , which 
were of statistical significance. Temperature readings were almost similar with 1-3' C 
change between the groups, which was similar to Wiltbank's (2007) results. The pH and 
temperature probes were connected and measurements were taken simultaneously. It is 
important to remember that this experiment was carried out at room temperature; when 
these materials are used in vivo different readings are expected. 
The setting time test showed the great differences between all groups. The control 
group took 195*18.027 minutes to set which is consistent with Torabinejad et a1 (1995 
&1999). The KY group had the shortest setting time 70*13.22 minutes, which have 
shown statistical significance. The CaC12 and NaOCl setting times were 123.33*2.88 and 
130* 13.22, respectively. CaC12 setting time was significantly shorter than control. Our 
results were different from previous research. Wiltbank et a1 (2007) had a setting time of 
35 minutes for the CaC12. However, the author used the Vickers hardness test and 
recorded the initial time to set. In this experiment the setting time was recorded when the 
stainless steel arm of the Gilmore apparatus failed to make an indentation on the cement 
surface. In a similar study Ber et a1 (2007) added to 2% CaC12 to eitherl%, 2%, or 3% 
methylcellulose (MC). Those 3 new additives were then mixed with either GMTA or PC 
to improve. These mixtures gave an approximately equal compressive strength, and sat 
three times faster (57 +/- 3 minutes) compared to 3-4 hours of regular GMTA. 
In our experiment mixing GMTA with the test materials resulted in a thick 
cement that handled similarly to IRM. It was easier to remove and handle compared to 
control group. However, these were experiments in vitro; the setting time might vary 
when the conditions of the experiment change to human or animal models. 
Mouse osteoblast cell attachment to the new cements surface was tested at 1 and 4 
days, using fluorescent microscopy. All groups showed cell attachment after 1 day. 
Group 3 (CaC12) had fewer cells attaching to the surface compared to the remaining 
groups. At day 4 the growth and attachment of cells in all groups was extensive. No 
differences in cell attachment were noted. 
In control disks, cells attached and spread on GMTA with water as well as 
composite. Limited number of cells attached to amalgam and IRM. Cells were rounded 
and showed no spreading. Similar results were obtained at day 4. Our results are 
consistent with Zhu et a1 2000. 
Torabinejad et a1 (1995) examined the periradicular tissue response of dogs to 
GMTA and amalgam. The periradicular tissue response of the dogs was evaluated 
histologically at 2 to 5 and 10 to 18 wks following periradicular surgery. The results 
showed less periradicular inflammation and more fibrous capsules adjacent to GMTA, 
compared with amalgam. In addition, the presence of cementum on the surface of GMTA 
was a frequent finding. 
In a similar study, Bemabe et a1 (2007) compared GMTA to Zinc Oxide Eugenol 
(ZoE). Histological examination was done after 180 days. Results showed cementum 
deposited only over GMTA. ZoE showed severe inflammation compared to GMTA. To 
observe the healing process with GMTA repaired root canal perforation, Holland et a1 
(2001) created lateral root perforation in 48 root canals of dog's teeth after complete 
instrumentation. The perforations were repaired with GMTA, and Sealapex was used as a 
control. At 30 and 180 days histological analysis was done. Results showed no 
inflammation and cementum deposition around MTA, while Sealapex was surrounded 
with chronic inflammation and slight deposition of cementum. 
In a retrospective human study Main et a1 (2004) looked at all repaired root 
perforations completed in the University of Loma Linda endodontic residency program. 
Only GMTA repaired perforation with radiographs and a minimum of 1 year recall were 
included. Only 16 patients met the criteria, 5 were strip perforations, 5 laterals, 3 furcal, 
and 3 apical perforations. All cases had preoperative radiolucency that decreased in size 
at 1 year recall. 
Karimjee et a1 (2006) compared the biocompatibility of WMTA mixed with water 
or with KY Jelly to that of Fuji I1 cement and amalgam. Periodontal ligament (PDL) cells 
were cultured. Eluates from mixed materials were placed in contact with the PDL cells 
for 24, 48, and 72 hours. Cell viability was determined by measuring mitochondria1 
enzyme activity using the MTT assay. Eluate extractions from all materials caused 
significantly less cell viability and more cell death than control at all times. However, at 
72 h the WMTNwater, MTAJKY, and amalgam eluate extractions led to significantly 
better cell viability than the Fuji I1 eluates. The author concluded that WMTNKY, 
WMTAJwater, and amalgam have similar biocompatibility regarding effects of their 
eluates on human PDL cells. 
The reviewed studies support the biocompatibility of GMTA when it's in contact 
with periapical tissue. Also these studies show MTA to be more biocompatible when 
compared with other commonly used root end filling materials. 
Hakki et a1 (2009) used different concentrations of MTA and tested cementoblast 
cell survival and gene expression. The results showed that 20mglmL concentration of 
MTA was toxic for cementoblasts, while using 0.02 mg/mL supported the survival of 
cells at 72 hrs period. Mineralization ability of the cells was also decreased with the 
increase in MTA concentration. However when smaller amount of cement was used with 
dentin disks, both mouse osteoblasts and fibroblasts showed continuous attachment to 
dentin and test cement surface. When compared to control disks mouse osteoblasts 
attached to GMTA and water as well as composite. Cells did not attach to IRM. Few cells 
attached to amalgam. Cells were rounded and showed no spreading. Fibroblasts showed 
similar results. This proves the biocompatibility of our test materials with the cells used. 
The reaction of osteoblasts to MTA was first tested by Koh et al (1997). In his 
study Koh used osteoblasts (MG-63) derived from human osteosarcoma. In all dishes 
cells were seen adhering to the base and GMTA at 6 h and had increased to confluence at 
144 h. IL-1 alpha, IL-1 beta, and IL-6 were raised when the cells were grown in the 
presence of GMTA at 144 h. M-CSF appeared to be unaffected although the overall 
value was high. Cells in contact with GMTA also appeared to have higher levels of 
alkaline phosphatase. 
In another study, Koh et a1 (1 998) used the same materials and methods to test the 
morphology of osteoblasts (MG-63) when grown with GMTA and IRM. SEM revealed 
healthy cells in contact with GMTA at 1 and 3 days; in contrast, cells in the presence of 
IRM appeared rounded. The ELISA assays revealed raised levels of all tested cytokines 
at all periods when cells were grown in the presence of GMTA; in contrast, cells grown 
alone or with IRM produced undetectable amounts. The author concluded that GMTA 
offers a biologically active substrate for bone cells and stimulates IL production. 
Mitchell and Pitt Ford (1999) carried out the same experiment using variant of 
GMTA. The authors did not specify the changes they made to GMTA; however their 
results were in agreement with Koh (1997 and 1998). Nakayama et a1 (2005) used bone 
cells from rat femur without specifying the cell line used. Materials used were GMTA 
and IRM. In the GMTA group, SEM showed that the cells attached in the same manner 
as the control group. The calcium released and ALP activity was similar to the control 
group. 
Tani-Ishii et a1 (2007) grew MC3T3-El cells with GMTA, amalgam and Dycal. 
RT-PCR with primer sets for type I collagen, osteocalcin, and bone sialoprotein was used 
to measure the gene-expression response of the cells with the tested materials. GMTA 
caused an up-regulation of type I collagen and osteocalcin messenger RNA expression 
after 24 hours. 
Cytokines levels were evaluated in this study using mouse macrophage cell line 
RAW 264.7. Macrophages were chosen because of their essential role in healing and 
inflammation. They produce variable cytokines the regulate bone formation. The results 
showed significant increase in TNF-a in the NaOCl group compared to control, which 
was consistent with Jafarnia et a1 (2009) results. KY group showed the least amount of 
TNF-a produced. CaClz groups produced similar levels when compared to control. There 
were no detectable changes for Interleukin- 1 alpha (IL- 1 a), Interleukin-1 beta (IL- 1 P), 
and Macrophage colony stimulating factor (M-CSF) when cells were cultured with the 
various MTA disks. 
Jafarnia et a1 (2009) used the same additives in our study. These additives were 
mixed with GMTA and WMTA to test the viability of mouse fibroblasts using MTT 
assay. The test and control cements were tested in freshly prepared and set state in the 
form of pellets measuring lmm in width x 1 mm in height. The author found when the 
material was set the additives had no effect on cell viability. While in freshly prepared 
NaOCl gel had the lowest cell viability ranging between 29% -50%. Both WMTA and 
GMTA had similar results. 
In our experiment all groups did not significantly stimulate cells to produce 
cytokines. This can be explained either by; materials used did not initiate a significant 
inflammatory reaction, or the number of live and active cells was too low to produce 
detectable amounts of cytokines. 
In a recent study by Huang et a1 (2008) 15% sodium phosphate dibasic 
(NazHP04) was used as an accelerant with White MTA. The author found setting time 
reduced to 26 minutes, pH increased to 13.2 and the tensile strength to be 4.9 MPa after 6 
hours. In a follow-up study by Ding et a1 (2008) the setting time was 38 minutes and 
fibroblasts showed attachment to both control and test group under SEM observation. 
This new material has not been fully tested for cytokines and it might provide a good 
alternative to MTA mixed with water. 
Conclusion: 
Under the conditions of this study, mouse MC3T3-El osteoblasts and L929 
mouse fibroblasts attached to the surface of GMTA and composite. Mouse MC3T3-El 
osteoblasts and L929 mouse fibroblasts did not attach to the surface of amalgam and 
IRM. Adding KY, CaC12, and NaOCl to grey MTA improved the handling properties and 
decreased setting time. Mouse osteoblasts and fibroblasts attached and spread on GMTA 
mixed with additives in a similar manner to GMTA mixed with water. These test cements 
could provide a possible alternative to GMTA mixed with water. Further in vitro 
investigations are required to prove the clinical applications of these materials. 
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